Sep 22, 2025, 06:33
Antiphospholipid Syndrome (APS) in Pregnancy – Key Takeaways
Dr. Mukesh, Assistant Professor of Clinical Immunology and Rheumatology at King George’s Medical University (KGMU), posted on X:
”Antiphospholipid Syndrome (APS) in Pregnancy – Key Takeaways
- APS affects 0.5% of the population but is a major cause of recurrent pregnancy loss (RPL), preeclampsia and FGR.
- Pathogenesis: “Two-hit model” → aPL antibodies trigger endothelial/placental dysfunction → thrombosis + insufficiency.
- Lupus anticoagulant (LA) = strongest predictor of poor outcomes.
- Standard of care: Low-dose aspirin (LDA) + LMWH → boosts live birth rates.
- Hydroxychloroquine (HCQ) reduces preterm birth and improves placental health in high-risk cases.
- Refractory APS? → Novel options: TNF-α inhibitors, complement blockers (eculizumab), nitric oxide modulators, statins.
- APS + SLE overlap = compounded risks → needs aggressive, multidisciplinary management.
- CAPS (catastrophic APS) = rare but lethal; pregnancy can trigger it (mortality ~36%).
- New 2023 ACR/EULAR criteria improve APS classification and risk stratification in pregnancy.
Bottom line: Early diagnosis, tailored therapy, and multidisciplinary care = better outcomes for mom and baby.”
Read the full review here.
Title: Antiphospholipid syndrome in pregnancy: a comprehensive literature review
Authors: Viorela Romina Murvai, Radu Galiș, Anca Panaitescu, Casandra Maria Radu, Timea Claudia Ghitea, Paula Trif, Miruna Onița-Avram, Alexandra Alina Vesa, Anca Huniadi

Stay updated with Hemostasis Today.
Alexandra Alina Vesa
Anca Huniadi
Anca Panaitescu
Antiphospholipid Syndrome
APS
Aspirin
BioMed Central
BMC
Casandra Maria Radu
Catastrophic APS
Health
Hematology
Hemostasis
Hemostasis Today
Heparin
Hydroxychloroquine
Immunology
in Pregnancy
King George's Medical University (KGMU)
LMWH
Low-Molecular-Weight Heparin
Lupus anticoagulant (LA)
Medicine
Miruna Onița-Avram
Mukesh
Paula Trif
Pregnancy
Radu Galiș
Recurrent Pregnancy Loss (RPL)
Rheumatology
thrombosis
Timea Claudia Ghitea
Viorela Romina Murvai
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera
